Facing unprecedented innovation and explosive growth in the life sciences industry, many leading biotechnology and pharmaceutical companies turn to Perkins Coie lawyers for strategic advice and practical counsel on expanding their business and protecting their intellectual property.
News
-
08.17.2023Best Lawyers® 2024 Recognizes 388 Perkins Coie LawyersPress ReleasesPerkins Coie is proud to announce that 388 of its lawyers have been recognized by Best Lawyers® 2024. A total of 275 attorneys were selected by their peers for inclusion in the 2024 edition of The Best Lawyers in America® and 113 attorneys were selected for inclusion in the 2024 edition of Best Lawyers: Ones to Watch.
-
08.18.2022Best Lawyers® 2023 Recognizes 403 Perkins Coie AttorneysPress ReleasesPerkins Coie is proud to announce that 403 of its attorneys have been recognized by Best Lawyers® 2023. A total of 279 attorneys were selected by their peers for inclusion in the 2023 edition of The Best Lawyers in America® and 124 attorneys were selected for inclusion in the 2023 edition of Best Lawyers: Ones to Watch.
-
12.16.2021Chief Diversity & Inclusion Officer Genhi Givings Bailey Quoted in PRNewswire—New "UCSF Rosenman RISE" Program Connects Underrepresented Healthtech Entrepreneurs With MentorsGeneral NewsGenhi Givings Bailey was quoted in the press release “New “UCSF Rosenman RISE” Program Connects Underrepresented Healthtech Entrepreneurs With Mentors,” on PRNewswire, regarding UCSF Rosenman RISE, a program that matches underrepresented CEO with mentors in the health technology field.
-
08.26.2021Best Lawyers® 2022 Recognizes 367 Perkins Coie AttorneysPress ReleasesPerkins Coie is proud to announce that 367 of its attorneys were recognized by the 2022 Best Lawyers®. A total of 278 attorneys were selected by their peers for inclusion in the 2022 edition of The Best Lawyers in America® and 89 attorneys were selected for inclusion in the 2022 edition of Best Lawyers: Ones to Watch.
-
03.01.2021Perkins Coie Partners and Practice Areas Recognized in 2021 Chambers Global GuidePress ReleasesPerkins Coie is proud to announce that six partners and three practice areas have been ranked by Chambers & Partners, publishers of the 2021 Chambers Global Guide, for exceptional work in the United States and China.
-
08.20.2020Best Lawyers® 2021 Recognizes 358 Perkins Coie AttorneysPress ReleasesPerkins Coie is proud to announce that 358 of its attorneys were recognized by Best Lawyers® 2021. A total of 290 attorneys were selected by their peers for inclusion in the 2021 edition of The Best Lawyers in America® and 68 attorneys were selected for inclusion in the inaugural edition of Best Lawyers: Ones to Watch.
-
03.05.2020Perkins Coie Partners and Practice Areas Recognized in 2020 Chambers Global GuidePress ReleasesPerkins Coie is proud to announce that six partners and three practice areas have been ranked by Chambers & Partners, publishers of the 2020 Chambers Global Guide, for exceptional work in the United States and China.
-
08.15.2019Best Lawyers® 2020 Recognizes 283 Perkins Coie AttorneysPress ReleasesPerkins Coie is proud to announce that 282 of its attorneys were selected by their peers for inclusion in the 2020 edition of The Best Lawyers in America®.
-
10.12.2018Perkins Coie Attorneys Mentioned in Law360 - Fed. Circ. Rules Teva's Copaxone Patents Are InvalidGeneral NewsDavid Anstaett, Shannon Bloodworth, Brandon White, Dan Bagatell, and Christina Jordan McCullough were mentioned in the Law360* article, "Fed. Circ. Rules Teva's Copaxone Patents Are Invalid," as representation for Mylan Pharmaceuticals Inc. Bloomberg also covered the decision in the article, "Teva Loses Appeal Over Four Patents for MS Drug Copaxone."
*Subscription-based publication -
10.12.2018Perkins Coie Client Win Reported by Mylan - Mylan Prevails in Copaxone® 40mg/mL Litigation Against Teva in U.S. Appellate CourtGeneral NewsPerkins Coie represented Mylan in its recent milestone Federal Circuit wins, relating to Glatiramer Acetate Injection 40mg/mL. The decision was reported in the Mylan article, "Mylan Prevails in Copaxone® 40mg/mL Litigation Against Teva in U.S. Appellate Court."
-
08.20.2018Best Lawyers® 2019 Recognizes 277 Perkins Coie AttorneysPress ReleasesPerkins Coie is proud to announce that 277 of its attorneys were selected by their peers for inclusion in the 2019 edition of The Best Lawyers in America®.
-
08.15.2018Perkins Coie Continues Emerging Companies & Venture Capital Growth with Addition of Palo Alto PartnerPress ReleasesPerkins Coie is pleased to announce that Matt Oshinsky has joined the firm’s Emerging Companies & Venture Capital (ECVC) practice as a partner in the Palo Alto office.
-
08.01.2018Perkins Coie Adds Two Commercial Litigation Partners in New YorkPress ReleasesPerkins Coie is pleased to announce that Edwin (Ed) M. Baum and Alan B. Howard have joined the firm’s Commercial Litigation practice as partners in the New York office. Ed and Alan will join the Securities Litigation and Business Litigation subgroups, respectively.
-
07.23.2018Perkins Coie Welcomes Leading Emerging Companies & Venture Capital Attorney in Palo AltoPress ReleasesPerkins Coie is pleased to announce that Adrian Rich has joined the firm’s Emerging Companies & Venture Capital practice as a partner in the firm’s Palo Alto office.
-
05.15.2018Perkins Coie Announces Life Sciences Blog: 1600 PTAB & BeyondPress ReleasesPerkins Coie is proud to announce the launch of 1600 PTAB & Beyond, a blog that reports from the intersection of the life sciences industry and key decisions and developments from the Patent Trial and Appeal Board (PTAB), district courts and appellate courts.
-
10.17.2017Perkins Coie Represents Attune Medical in Securing $10 Million Series C FinancingPress ReleasesPerkins Coie represented Attune Medical, the developer of EnsoETM, the only patient temperature management system approved for use in the esophageal environment for whole-body temperature modulation, in the close of a $10 million Series C financing with participation from existing investors, several associates, and new investors.
-
08.15.201735 Perkins Coie Attorneys Named 2018 Lawyers of the Year by Best Lawyers®Press ReleasesPerkins Coie is proud to announce that 35 of its attorneys have been named 2018 Lawyers of the Year by Best Lawyers®.
-
08.15.2017Best Lawyers® 2018 Recognizes 281 Perkins Coie AttorneysPress ReleasesPerkins Coie is proud to announce that 281 of its attorneys were selected by their peers for inclusion in the 2018 edition of The Best Lawyers In America®.
-
08.15.2016Best Lawyers® 2017 Recognizes 252 Perkins Coie AttorneysPress ReleasesPerkins Coie is proud to announce that 252 of its attorneys were selected by their peers for inclusion in the 2017 edition of The Best Lawyers In America®, the oldest and most respected peer-review publication in the legal profession.
-
05.24.2016Dr. Justin A. Roby Receives 2016 Perkins Coie Award For DiscoveryPress ReleasesPerkins Coie is pleased to announce that Dr. Justin A. Roby, Senior Fellow, Department of Immunology at the University of Washington, has been selected to receive the Perkins Coie 2016 Award For Discovery and accompanying $20,000 grant.
-
03.16.2016Perkins Coie Boosts Life Sciences Practice with Addition of Seasoned Technology Transactions PartnerPress ReleasesPerkins Coie is pleased to announce that Mark R. Wicker has joined the firm’s Technology Transactions & Privacy practice as a partner in San Diego.
-
08.17.201535 Perkins Coie Attorneys Named 2016 Lawyers of the Year by Best Lawyers®Press ReleasesPerkins Coie is proud to announce that 35 of its attorneys have been named 2016 Lawyers of the Year by Best Lawyers®, the oldest and most respected peer-review publication in the legal profession.
-
08.17.2015Best Lawyers® 2016 Recognizes 245 Perkins Coie AttorneysPress ReleasesPerkins Coie is proud to announce that 245 of its attorneys were selected by their peers for inclusion in the 2016 edition of The Best Lawyers In America®, the oldest and most respected peer-review publication in the legal profession; a more than 10 percent increase over the 221 firm attorneys recognized by Best Lawyers in the 2015 edition.
-
04.28.2015Lucrezia Colonna Receives 2015 Perkins Coie “Award For Discovery”Press ReleasesPerkins Coie is pleased to announce that Dr. Lucrezia Colonna, Postdoctoral Fellow, Department of Rheumatology/Medicine at the University of Washington, has received the $20,000 Perkins Coie 2015 "Award for Discovery."
-
02.11.2015Three Perkins Coie Partners Named Among The BTI Client Service All Stars 2015Press ReleasesPerkins Coie is pleased to announce that Craig Boggs, David Clarke and Chuck Samel were named among the 354 attorneys named by BTI Consulting to its list of Client Service All Stars 2015 as “the individuals clients think of - and turn to - first” because “they service clients better than anyone and everyone.”
-
01.14.2015Perkins Coie Expands Business Practice in ChicagoPress Releases
Perkins Coie is pleased to announce that LaDale K. George has joined the Chicago office as a partner in the firm’s Healthcare industry group. LaDale was previously a partner at Neal, Gerber & Eisenberg.
-
01.06.2015Perkins Coie Announces 2015 Partner ClassPress ReleasesPerkins Coie announced that 21 associates, counsel and senior counsel have been promoted to partner. “The members of Perkins Coie's 2015 partner class are talented, hard-working attorneys who embody the national strength and forward-looking growth of our firm,” said John Devaney, Perkins Coie's Firmwide Managing Partner.
-
05.15.2014Farid Moussavi-Harami Receives 2014 Perkins Coie “Award for Discovery”Press ReleasesPerkins Coie is pleased to announce that Dr. Farid Moussavi-Harami, Acting Instructor/Senior Fellow, Department of Internal Medicine, Division of Cardiology at the University of Washington, has received the $20,000 Perkins Coie 2014 “Award for Discovery.”
-
06.13.2011Perkins Coie Awards Grant for Nanoengineering Patch to Repair Heart Attack DamageGeneral News